One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
News-Medical.Net on MSN
Rituximab shows remarkable success in adults with relapsing nephrotic syndrome
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
The randomized, open-label INSHORE trial (ClinicalTrials.gov Identifier: NCT05627557) evaluated the safety and efficacy of obinutuzumab in children and young adults in clinical remission aged 2 to 25 ...
Dr. Margot E. Manning (Medicine): A 32-year-old woman was admitted to this hospital because of flank pain, fever, and hypoxemia. Two weeks before the current presentation, sharp, intermittent pain in ...
Former NFL star Nick Mangold, 41, has passed away after a battle with kidney disease, a stark reminder of its severity.
Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback